Methadone, Buprenorphine and the Community Online
This course meets the training requirements (minimum every five years) for pharmacists dispensing methadone.
$0.00
Description
Description:
This program requires learners to attend 2 webinars (both parts 1 & 2) of their choosing. After registering, you’ll receive access to a Zoom link that will allow you to attend any of the following presentations:
December 2026
- Part 1 – December 9, 2026, 6:00 pm – 9:00 pm
- Part 2 – December 10, 2026, 6:00 pm – 8:00 pm
February 2027
- Part 1 – February 23, 2027, 6:00 pm – 9:00 pm
- Part 2 – February 25, 2027, 6:00 pm – 8:00 pm
Please note recordings of the presentations will not be provided, as it is a course completion requirement to attend the webinars.
Learning Objectives:
Opioid Agonist Therapy (45 minutes)
- Identify those at risk for opioid use disorder.
- Discuss treatment options for OUD.
- Review safe prescribing and dispensing of opioid agonist therapy.
- Outline the components of a comprehensive OAT program.
- Discuss strategies for interprofessional collaboration and to reduce stigma.
Opioid Agonist Therapy: Special Topics (45 minutes)
- Identify options for pain control for patients on Opioid Agonist Therapies.
- Discuss co-prescribing of benzodiazepines with OAT.
- Review management of pregnant patients with Opioid Use Disorder.
- Explore the role of the pharmacist in harm reduction.
Policies Guiding Methadone Dispensing in Ontario (30 minutes)
- Identify CPSO and OCP policies that pharmacists should refer to when dispensing methadone in Ontario.
- Review current OCP Opioid Policy.
- Review labelling, documentation, and staff training requirements for dispensing methadone.
- List required and additional references and resources for dispensing methadone.
- Review buprenorphine/naloxone dispensing.
Operationalizing Methadone Dispensing Policies in Ontario (1 hour)
- Review and describe OCP Opioid Policy for dispensing methadone in Ontario
- Describe how OCP Opioid Policy and best practices can be implemented in your pharmacy practice.
- Find practical resources and tools to work and run OAMT dispensing pharmacies.
Destigmatizing Opioid Use Disorder (30 minutes)
- Describe the impact of stigma on patients with opioid use disorder.
- Communicate effectively through the use of non-stigmatizing language when dealing with sensitive or discrete issues.
Beyond the Stigma (40 minutes – this section is unaccredited)
- Learn about stigma from the perspective of a pharmacist with 16 years of experience dispensing OAT.
- Reflect on common myths about patients with substance use disorders and dispensing OAT.
- Consider ways to address stigma and offer support.
Course at a Glance:

- 5.5 hours to complete
- 5.5 CEUs
- Course expiry date: October 22, 2027
- Webinar
- Accreditation: 8003-2021-3329-L-P
- Completion Requirement: Attend the webinars (both Parts 1 & 2) and complete the declaration of attendance, the multiple-choice exam (with a score of 70 per cent or higher) and the program evaluation before the expiry date to receive a letter of completion.
Intended Audience:
Successful completion of this course qualifies as an approved training course as part of their training update for pharmacists dispensing methadone. Updates are required at minimum every five years as indicated in the Ontario College of Pharmacists’ Opioid Policy. Please note that this course does not replace the CAMH Opioid Use Disorder (OUDT) course, which Designated Managers and pharmacists are required to complete to dispense methadone as outlined in the Ontario College of Pharmacists’ Opioid Policy. This course is open and applicable to all pharmacy professionals including students and pharmacy technicians. Any pharmacy professionals who are interested in or currently dispensing methadone are welcome to attend.
Development Team:
- Michelle Klaiman, MD, FRCPC, DABAM
- Lisa Lefebvre, MD (MDCM, MPH, CCFP(AM), DABAM, FASAM, CCSAM, CMRO)
- Juno Kim, RPh (PharmD)
- Jatinder Dhaliwall, RPh (BSc Pharm)
Our Commitment:
OPA is committed to providing high-quality, accurate, and unbiased educational content, tools, and resources for healthcare professionals and patients. Learn more about our process for content development and what it means to be a CCCEP accredited provider here.
Cancelation Policy:
Please refer to OPA’s Terms and Conditions of Purchase for cancellation policies.
Sponsor:
This course is supported by funding from the Mental Health and Addiction Centre of Excellence of Ontario Health.
OPA programs you may also like
-
- Sale!
- Prescribing for Minor Ailments – Full 19 Conditions
-
$279.00$229.00 - Education
